FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202770503> ?p ?o ?g. }

• W3202770503 endingPage "e351" @default.
• W3202770503 startingPage "e319" @default.
• W3202770503 abstract "The combination of vancomycin and piperacillin/tazobactam (VAN + PTZ) provides a broad spectrum of activity against multiple pathogens. However, a major issue in previous research concerned significant nephrotoxicity associated with this drug combination, and most studies have been conducted in American and European countries, with no similar data available from China. Therefore, this study evaluated the nephrotoxic effects of VAN + PTZ in a large-scale Chinese cohort to determine the prevalence of acute kidney injury (AKI) in this population by comparing PTZ and vancomycin monotherapies and the combined use of vancomycin and β-lactam antibiotics.This retrospective cohort study identified adult patients who received vancomycin either as monotherapy or in combination with PTZ or carbapenem (VAN + CAR) for at least 48 hours at Jiangsu Province Hospital from January 1, 2017, to December 31, 2018. Patients were also evaluated for the development of AKI, defined according to the Kidney Disease Improving Global Outcome criteria. Duration of vancomycin exposure, steady-state trough vancomycin concentrations, and other risk factors for AKI were assessed. A Bayesian network meta-analysis was conducted to validate our results and comparatively evaluate the nephrotoxicity of β-lactam antibiotics in combination with vancomycin.In all, 752 patients were included in the present study. The prevalence of AKI was higher in the VAN + PTZ group than in the VAN and VAN + CAR groups (15.2% vs 4.0% and 6.0%, respectively). After adjustment for confounding factors, VAN + PTZ was still related to AKI (odds ratio [OR] = 4.37; 95% CI, 1.65-11.59; P = 0.003). The network meta-analysis indicated that VAN + PTZ was associated with a significantly higher risk for AKI than was VAN (OR = 3.23; 95% CI, 2.50-4.35), PTZ (OR = 2.86; 95% CI, 1.92-4.12), VAN + cefepime (FEP) (OR = 2.37; 95% CI, 1.80-3.19), or VAN + CAR (OR = 2.28; 95% CI, 1.64-3.21). However, there was no significant difference with respect to AKI prevalence among the VAN, PTZ, VAN + FEP, and VAN + CAR groups.The prevalence of AKI was higher with VAN + PTZ therapy than with VAN or PTZ monotherapy or with the concurrent use of VAN and FEP or CAR in our study. Clinicians should adequately assess renal function and consider this differential risk for nephrotoxicity when choosing empiric antibiotics in hospitalized patients to minimize the rates of AKI." @default.
• W3202770503 created "2021-10-11" @default.
• W3202770503 creator A5001094449 @default.
• W3202770503 creator A5005103207 @default.
• W3202770503 creator A5014063892 @default.
• W3202770503 creator A5045570568 @default.
• W3202770503 creator A5051587942 @default.
• W3202770503 creator A5057582121 @default.
• W3202770503 creator A5061817335 @default.
• W3202770503 date "2021-10-01" @default.
• W3202770503 modified "2023-09-27" @default.
• W3202770503 title "Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study" @default.
• W3202770503 cites W1729901684 @default.
• W3202770503 cites W1812368248 @default.
• W3202770503 cites W1899190379 @default.
• W3202770503 cites W1899848528 @default.
• W3202770503 cites W1967300023 @default.
• W3202770503 cites W1972725951 @default.
• W3202770503 cites W1974917104 @default.
• W3202770503 cites W1998816241 @default.
• W3202770503 cites W2005918477 @default.
• W3202770503 cites W2010699829 @default.
• W3202770503 cites W2026274122 @default.
• W3202770503 cites W2070100153 @default.
• W3202770503 cites W2075535893 @default.
• W3202770503 cites W2076664566 @default.
• W3202770503 cites W2080433928 @default.
• W3202770503 cites W2091808438 @default.
• W3202770503 cites W2103667022 @default.
• W3202770503 cites W2126930838 @default.
• W3202770503 cites W2139937737 @default.
• W3202770503 cites W2144625636 @default.
• W3202770503 cites W2155965977 @default.
• W3202770503 cites W2206769413 @default.
• W3202770503 cites W2254489490 @default.
• W3202770503 cites W2296006889 @default.
• W3202770503 cites W2322967334 @default.
• W3202770503 cites W2531537514 @default.
• W3202770503 cites W2537843951 @default.
• W3202770503 cites W2557572134 @default.
• W3202770503 cites W2588779940 @default.
• W3202770503 cites W2591595902 @default.
• W3202770503 cites W2614972205 @default.
• W3202770503 cites W2734604705 @default.
• W3202770503 cites W2753730550 @default.
• W3202770503 cites W2776894069 @default.
• W3202770503 cites W2777264543 @default.
• W3202770503 cites W2780623748 @default.
• W3202770503 cites W2796817276 @default.
• W3202770503 cites W2800604386 @default.
• W3202770503 cites W2885889074 @default.
• W3202770503 cites W2887297384 @default.
• W3202770503 cites W2888281395 @default.
• W3202770503 cites W2890556091 @default.
• W3202770503 cites W2909118206 @default.
• W3202770503 cites W2913107568 @default.
• W3202770503 cites W2918044970 @default.
• W3202770503 cites W2940061256 @default.
• W3202770503 cites W2948126595 @default.
• W3202770503 cites W2955920860 @default.
• W3202770503 cites W2980618747 @default.
• W3202770503 cites W2993595882 @default.
• W3202770503 cites W3025631239 @default.
• W3202770503 cites W3048556001 @default.
• W3202770503 cites W3108112923 @default.
• W3202770503 cites W3120242683 @default.
• W3202770503 doi "https://doi.org/10.1016/j.clinthera.2021.08.008" @default.
• W3202770503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34579971" @default.
• W3202770503 hasPublicationYear "2021" @default.
• W3202770503 type Work @default.
• W3202770503 sameAs 3202770503 @default.
• W3202770503 citedByCount "2" @default.
• W3202770503 countsByYear W32027705032022 @default.
• W3202770503 countsByYear W32027705032023 @default.
• W3202770503 crossrefType "journal-article" @default.
• W3202770503 hasAuthorship W3202770503A5001094449 @default.
• W3202770503 hasAuthorship W3202770503A5005103207 @default.
• W3202770503 hasAuthorship W3202770503A5014063892 @default.
• W3202770503 hasAuthorship W3202770503A5045570568 @default.
• W3202770503 hasAuthorship W3202770503A5051587942 @default.
• W3202770503 hasAuthorship W3202770503A5057582121 @default.
• W3202770503 hasAuthorship W3202770503A5061817335 @default.
• W3202770503 hasConcept C126189478 @default.
• W3202770503 hasConcept C126322002 @default.
• W3202770503 hasConcept C156957248 @default.
• W3202770503 hasConcept C167135981 @default.
• W3202770503 hasConcept C177713679 @default.
• W3202770503 hasConcept C2777637488 @default.
• W3202770503 hasConcept C2777858937 @default.
• W3202770503 hasConcept C2778193466 @default.
• W3202770503 hasConcept C2778980435 @default.
• W3202770503 hasConcept C2779489039 @default.
• W3202770503 hasConcept C2780091579 @default.
• W3202770503 hasConcept C2780472472 @default.
• W3202770503 hasConcept C501593827 @default.
• W3202770503 hasConcept C523546767 @default.
• W3202770503 hasConcept C54355233 @default.
• W3202770503 hasConcept C71924100 @default.

• next